Dow Down 0.18% Nasdaq Up 0.39%

Novavax, Inc. (NVAX)

-NasdaqGS
4.88 Up 0.19(4.05%) 4:00PM EDT
|After Hours : 4.88 0.00 (0.00%) 4:24PM EDT
Prev Close:4.69
Open:4.75
Bid:4.75 x 1000
Ask:5.11 x 200
1y Target Est:10.40
Beta:1.04
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.70 - 4.89
52wk Range:2.68 - 6.95
Volume:4,350,994
Avg Vol (3m):3,800,450
Market Cap:1.16B
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXUp 4.05%1.16B
MRKDown 0.53%172.47B
NVSUp 4.31%227.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.28
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback